Peri-interventional control of haemostasis in a patient with combined coagulation factor V- and factor VIII-deficiency and anaphylaxis to fresh frozen plasma - a rare indication for recombinant factor VIIa.
Lechner
D
D
Eichinger
S
S
Wanivenhaus
A
A
Kyrle
P A
PA
D000707:Anaphylaxis / Q000209:etiology* / Q000517:prevention & control; D001174:Arthrodesis / Q000379:methods; D001845:Bone Cysts / Q000601:surgery; D005166:Factor V Deficiency / Q000188:drug therapy*; D015942:Factor VIIa / Q000627:therapeutic use*; D006467:Hemophilia A / Q000150:complications* / Q000188:drug therapy*; D006470:Hemorrhage / Q000517:prevention & control*; D006487:Hemostasis / Q000502:physiology; D006801:Humans; D008297:Male; D008875:Middle Aged; D010949:Plasma; D011994:Recombinant Proteins / Q000627:therapeutic use; D013380:Subtalar Joint / Q000601:surgery; D065227:Transfusion Reaction; D016896:Treatment Outcome
D011994:Recombinant Proteins; C103587:recombinant FVIIa; D015942:Factor VIIa